Optimal Industrial Technologies

 

Upcoming Webinars

https://biopharmawebinars.com/webinars/to-release-or-not-to-release-microbial-impact-assessment-of-bioburden-limit-excursions/

Microbial Impact Assessment of In-Process Bioburden Limit Excursions

Presented by Friedrich von Wintzingerode, PhD. Director, Microbiology and QC individualized and cell therapy at Genentech, Cheryl Essex, MS. Head of Contamination Control, R&D Global Quality at Sanofi and Jon Kallay, Senior Scientific Portfolio Specialist, Charles River Microbial Solutions
20th March 2025

https://biopharmawebinars.com/webinars/grouping-extractable-and-leachable-el-compounds-with-a-common-mechanism-of-action-for-toxicological-risk-assessment/

Grouping Extractable and Leachable (E&L) Compounds with a Common Mechanism of Action for Toxicological Risk Assessment

Presented by Ron Brown, Toxicologist at Risk Science Consortium, Philippe Verlinde, Ph.D. Senior Technical Advisor at Nelson Labs
25th March 2025

https://biopharmawebinars.com/webinars/cmc-progression-from-early-to-late-phase-practical-considerations-for-gene-therapy-2/

CMC Progression from Early to Late Phase – Practical Considerations for Gene Therapy

Presented by Sarah Thomas, Senior Vice President of Quality at REGENXBIO Inc.
27th March 2025

https://biopharmawebinars.com/webinars/design-of-a-global-risk-based-personnel-monitoring-assessment-for-a-multi-production-operation-company/

Design of a Global Risk-Based Personnel Monitoring Assessment for a Multi-Production Operation Company

Presented by Luyen Nguyen Global Sterility Assurance and Microbiology Lead at Takeda, Hilary Chan Global Sterility Assurance and Microbiology Lead at Takeda
10th April 2025

 

On Demand Webinars

https://biopharmawebinars.com/webinars/navigating-the-complexities-of-mrna-therapies-analysis-challenges-techniques-and-quality-assessment-strategies/

Navigating the Complexities of mRNA Therapies Analysis: Challenges, Techniques, and Quality Assessment Strategies

Presented by Sarita Kattel, M.S, Principal Scientist, Global Biologics at USP, Khaled Yamout, CEO at Yamout Chem Consulting, LLC, Martin Gilar, Ph.D., Scientific Fellow, Seperations R&D group at Water Corporation, Roxanna Eggleston-Rangel, Applications Scientist at Phenomenex
27th February 2025

https://biopharmawebinars.com/webinars/case-study-a-risk-based-approach-to-material-transfer-validation/

Case Study: A Risk-Based Approach to Material Transfer Validation

Presented by Presented by Liz Brockson, Aseptic Processing and Sterility Assurance Lead in Global Sterility Assurance and Microbiology at Takeda
19th February 2025

https://biopharmawebinars.com/webinars/the-critical-role-of-conversion-factor-in-quantitative-determination-of-host-cell-dna-with-dpcr/

The Critical Role of Conversion Factor in Quantitative Determination of Host Cell DNA with dPCR

Presented by Haiqing Yu, Senior Scientist, Analytical Development Department at Sanofi.
04th February 2025

https://biopharmawebinars.com/webinars/deciphering-empty-full-characterization-a-comparative-analysis-of-available-analytical-methods/

Deciphering Empty-Full Characterization: A Comparative Analysis of Available Analytical Methods

Presented by Binod Pandey, Senior Scientist at Novartis
03rd February 2025